SE432930B - Sett att framstella 2-oxo-2,3-dihydro-3-bens/b/tiofenkarboxamid-derivat - Google Patents

Sett att framstella 2-oxo-2,3-dihydro-3-bens/b/tiofenkarboxamid-derivat

Info

Publication number
SE432930B
SE432930B SE7704033A SE7704033A SE432930B SE 432930 B SE432930 B SE 432930B SE 7704033 A SE7704033 A SE 7704033A SE 7704033 A SE7704033 A SE 7704033A SE 432930 B SE432930 B SE 432930B
Authority
SE
Sweden
Prior art keywords
thiophencarboxamide
benz
dihydro
oxo
derivative
Prior art date
Application number
SE7704033A
Other languages
English (en)
Swedish (sv)
Other versions
SE7704033L (sv
Inventor
R Bernasconi
P G Ferrini
R Goschke
J Gosteli
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH453876A external-priority patent/CH630082A5/de
Priority claimed from CH1599476A external-priority patent/CH629797A5/de
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SE7704033L publication Critical patent/SE7704033L/xx
Publication of SE432930B publication Critical patent/SE432930B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/64—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SE7704033A 1976-04-09 1977-04-06 Sett att framstella 2-oxo-2,3-dihydro-3-bens/b/tiofenkarboxamid-derivat SE432930B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH453876A CH630082A5 (de) 1976-04-09 1976-04-09 Verfahren zur herstellung von oxothiaverbindungen.
CH1599476A CH629797A5 (en) 1976-12-20 1976-12-20 Process for the preparation of salts of oxothia compounds

Publications (2)

Publication Number Publication Date
SE7704033L SE7704033L (sv) 1977-10-10
SE432930B true SE432930B (sv) 1984-04-30

Family

ID=25695718

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7704033A SE432930B (sv) 1976-04-09 1977-04-06 Sett att framstella 2-oxo-2,3-dihydro-3-bens/b/tiofenkarboxamid-derivat

Country Status (27)

Country Link
US (1) US4320138A (no)
JP (1) JPS52125158A (no)
AR (3) AR218869A1 (no)
AT (1) AT357148B (no)
CA (1) CA1112248A (no)
CS (4) CS207394B2 (no)
CY (1) CY1138A (no)
DD (1) DD130659A5 (no)
DE (1) DE2713584C2 (no)
DK (1) DK152046C (no)
ES (1) ES457528A1 (no)
FI (1) FI69461C (no)
FR (1) FR2347363A1 (no)
GB (1) GB1544339A (no)
GR (1) GR70652B (no)
HK (1) HK6182A (no)
HU (1) HU180438B (no)
IE (1) IE44987B1 (no)
IL (1) IL51847A (no)
KE (1) KE3185A (no)
MY (1) MY8200244A (no)
NL (1) NL7703802A (no)
NO (1) NO146810C (no)
NZ (1) NZ183747A (no)
PL (3) PL110653B1 (no)
SE (1) SE432930B (no)
SU (4) SU795475A3 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH634840A5 (de) * 1978-06-29 1983-02-28 Ciba Geigy Ag 2-oxo-2,3-dihydro-benzo(b)thiophen-verbindung und daraus hergestellte pharmazeutische praeparate.
AT392787B (de) * 1978-06-29 1991-06-10 Ciba Geigy Ag Verfahren zur herstellung des neuen n-(2-thienyl)-2-oxo-2,3-dihydro-benzo(b)thiophen-3-carboxamids

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3413308A (en) * 1966-09-02 1968-11-26 Dow Chemical Co Substituted benzo(b)thiophene-2-carboxanilides
US3655693A (en) * 1969-06-25 1972-04-11 Merck & Co Inc Anti-inflammatory salicyclic acid derivatives
US3676463A (en) * 1970-10-15 1972-07-11 Pfizer Oxobenzofuran carboxamides
US3971814A (en) * 1972-11-27 1976-07-27 Warner-Lambert Company Benzo(b)thiophene derivatives
GB1571847A (en) * 1974-01-02 1980-07-23 Systems Eng & Mfg Waste water treatment

Also Published As

Publication number Publication date
IE44987B1 (en) 1982-06-02
CY1138A (en) 1982-05-07
DD130659A5 (de) 1978-04-19
SE7704033L (sv) 1977-10-10
ES457528A1 (es) 1978-08-16
FI69461B (fi) 1985-10-31
NZ183747A (en) 1979-01-11
IL51847A (en) 1981-09-13
IE44987L (en) 1977-10-09
NL7703802A (nl) 1977-10-11
DK152046C (da) 1988-07-18
HU180438B (en) 1983-03-28
GR70652B (no) 1982-12-03
PL111456B1 (en) 1980-08-30
PL110653B1 (en) 1980-07-31
SU898956A3 (ru) 1982-01-15
CS207392B2 (en) 1981-07-31
CS207395B2 (en) 1981-07-31
ATA248577A (de) 1979-11-15
PL111459B1 (en) 1980-08-30
SU795475A3 (ru) 1981-01-07
AR218869A1 (es) 1980-07-15
CS207393B2 (en) 1981-07-31
JPS52125158A (en) 1977-10-20
CA1112248A (en) 1981-11-10
NO146810B (no) 1982-09-06
HK6182A (en) 1982-02-19
CS207394B2 (en) 1981-07-31
AR224614A1 (es) 1981-12-30
PL197311A1 (pl) 1978-01-16
FR2347363A1 (fr) 1977-11-04
DE2713584A1 (de) 1977-10-20
JPS6218556B2 (no) 1987-04-23
FI771044A (no) 1977-10-10
SU791239A3 (ru) 1980-12-23
DK152046B (da) 1988-01-25
IL51847A0 (en) 1977-06-30
GB1544339A (en) 1979-04-19
AR225401A1 (es) 1982-03-31
FI69461C (fi) 1986-02-10
DE2713584C2 (de) 1986-09-04
SU738510A3 (ru) 1980-05-30
FR2347363B1 (no) 1979-03-09
US4320138A (en) 1982-03-16
DK158777A (da) 1977-10-10
MY8200244A (en) 1982-12-31
NO146810C (no) 1982-12-15
KE3185A (en) 1982-04-02
NO771231L (no) 1977-10-11
AT357148B (de) 1980-06-25

Similar Documents

Publication Publication Date Title
SE413237C (sv) Sett att framstella finkornig, amorf, felld kiseldioxid
SE440779B (sv) Sett att framstella androstan-17-on-derivat
SE429551B (sv) Sett att framstella 1-(3-dimetylamino-propyl)-ftalanderivat
SE7805276L (sv) Sett att framstella liposomblandningar
SE433222B (sv) Sett att framstella modifierad polysackarid
SE431935B (sv) Sett att framstella drageer
SE7606280L (sv) Sett att framstella etrar
SE7607152L (sv) Sett att framstella nya 2-piperidinoalkyl-1,4-bensdioxaner
SE441042B (sv) Sett att pavisa rheumatoida faktorer
SE432256B (sv) Sett att framstella cellulosaalkyletrar
SE430687B (sv) Sett att framstella hexanitrostilben
SE420732B (sv) Sett att framstella 4-gonen-3-oner
SE425321B (sv) Sett att reducera vanadinoxider
SE7804126L (sv) Sett att framstella vulkanisat
SE7710042L (sv) Sett att aterupphetta platemnen
SE434397B (sv) Sett att framstella bens-acyl-bensimidazol-2-derivat
SE7714506L (sv) Sett att framstella packningar
SE425850B (sv) Sett att framstella abietamidderivat.
SE430156B (sv) Sett att framstella 2-subst-1-(omega-aminoalkoxi)-bensener
SE433213B (sv) Sett att framstella 2 -fenyl-3-amino-benso/b/tiofenderivat
SE431324B (sv) Sett att framstella trifenylalkaenderivat
SE420731B (sv) Sett att framstella 5-androsten-17-on-derivat
SE7709051L (sv) Sett att framstella prostanderivat
SE7704055L (sv) Sett att framstella nya naftalenderivat
SE432930B (sv) Sett att framstella 2-oxo-2,3-dihydro-3-bens/b/tiofenkarboxamid-derivat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7704033-5

Effective date: 19931110

Format of ref document f/p: F